UBS lowered the firm’s price target on Mondelez (MDLZ) to $62 from $63 and keeps a Neutral rating on the shares. The firm thinks Q1 results for much of the consumer staples group will be “okay” as organic revenue growth will show signs of improvement and stabilization, though the issue centers on how companies will handle forward looking commentary as inflation is likely to pose a greater risk to earnings in the second half and potentially beyond, the analyst tells investors in a preview for the group.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDLZ:
- Mondelez price target lowered to $54 from $60 at Deutsche Bank
- The Week That Was, The Week Ahead: Macro and Markets, Mar. 29
- Midday Fly By: Merck to acquire Terns, Arm CPU launch applauded
- Arm upgraded, Mondelez downgraded: Wall Street’s top analyst calls
- Mondelez downgraded to Neutral from Buy at Rothschild & Co Redburn
